Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 2Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Genitourinary 1Breast 1

Conditions

Lymphoma, Non-Hodgkin 70Lymphoma, Large B-Cell, Diffuse 67Lymphoma 66Lymphoma, Follicular 59Leukemia, Lymphocytic, Chronic, B-Cell 58Lymphoma, B-Cell, Marginal Zone 30Burkitt Lymphoma 30Waldenstrom Macroglobulinemia 24Lymphoma, Mantle-Cell 24Lymphoma, B-Cell 24Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Leukemia 19Recurrence 17Hodgkin Disease 12Neoplasms 10Lymphoma, Large-Cell, Immunoblastic 10Multiple Myeloma 8Leukemia, Prolymphocytic 8Leukemia, Myeloid, Acute 8Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7Myelodysplastic Syndromes 7Mycosis Fungoides 6Lymphoma, T-Cell, Cutaneous 6Leukemia, Hairy Cell 6Sezary Syndrome 5Neoplasms, Plasma Cell 5Lymphoma, Large-Cell, Anaplastic 5Lymphoma, Extranodal NK-T-Cell 5Intraocular Lymphoma 5Dendritic Cell Sarcoma, Interdigitating 5

Interventions

Cyclophosphamide 6Isotretinoin 5thymoglobulin 4fludarabine phosphate 4fludarabine 4aldesleukin 4Topotecan 4Temozolomide 4Melphalan 4Irinotecan 4Etoposide 4ribociclib 3Thiotepa 3Interleukin-2 3Granulocyte Colony-Stimulating Factor 3Filgrastim 3Busulfan 3Bone Marrow Transplantation 3Antilymphocyte Serum 3temsirolimus 2omburtamab I-131 2dinutuximab 2Vincristine 2Tretinoin 2TPI-287 2Stem Cell Transplantation 2Rituximab 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Nivolumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Neuroblastoma × Rituximab × Clear all
NCT00202930 2021-01-22

Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma

University of Pittsburgh

Phase 2 Terminated
4 enrolled 6 charts
CNS

Neuroblastoma, Opsoclonus-Myoclonus Syndrome

NCT00617929 2017-12-28

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
12 enrolled 12 charts
BreastCNSGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Pdgfra-Associated Chronic Eosinophilic Leukemia, Carcinoma, Ovarian Epithelial, Breast Neoplasms, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Wilms Tumor, Neuroblastoma, Recurrence, Rhabdomyosarcoma, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡